tiprankstipranks
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
:2607
Hong Kong Market
2607
Shanghai Pharmaceuticals Holding Co
RESEARCH TOOLSreports
Want to see HK:2607 full AI Analyst Report?

Shanghai Pharmaceuticals Holding Co (2607) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

2607 Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Shanghai
Pharmaceuticals Holding Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2607 Stock 12 Month Forecast

Average Price Target

HK$13.50
▲(13.35% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Shanghai Pharmaceuticals Holding Co in the last 3 months. The average price target is HK$13.50 with a high forecast of HK$13.50 and a low forecast of HK$13.50. The average price target represents a 13.35% change from the last price of HK$11.91.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"HK$9","14":"HK$14","10.25":"HK$10.25","11.5":"HK$11.5","12.75":"HK$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":13.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$13.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$13.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$13.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,10.25,11.5,12.75,14],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.67,11.81076923076923,11.951538461538462,12.092307692307692,12.233076923076924,12.373846153846154,12.514615384615384,12.655384615384616,12.796153846153846,12.936923076923076,13.077692307692308,13.218461538461538,13.35923076923077,{"y":13.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.67,11.81076923076923,11.951538461538462,12.092307692307692,12.233076923076924,12.373846153846154,12.514615384615384,12.655384615384616,12.796153846153846,12.936923076923076,13.077692307692308,13.218461538461538,13.35923076923077,{"y":13.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.67,11.81076923076923,11.951538461538462,12.092307692307692,12.233076923076924,12.373846153846154,12.514615384615384,12.655384615384616,12.796153846153846,12.936923076923076,13.077692307692308,13.218461538461538,13.35923076923077,{"y":13.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.903,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.228,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.076,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.269,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.359,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.141,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.141,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.578,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.726,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.38,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.6,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":11.57,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":11.67,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$13.50Average Price TargetHK$13.50Lowest Price TargetHK$13.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on HK:2607
Unknown Analyst
Citi
Not Ranked
Citi
HK$13.5
Buy
13.35%
Upside
Reiterated
04/13/26
Shanghai Pharmaceuticals Holding Co (SHPMF) Receives a Buy from Citi
HSBC Analyst forecast on HK:2607
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$12.1→HK$11.8
Sell
-0.92%
Downside
Reiterated
11/10/25
HSBC Remains a Sell on Shanghai Pharmaceuticals Holding Co (SHPMF)
CICC Analyst forecast on HK:2607
Unknown Analyst
CICC
Not Ranked
CICC
HK$14.7
Buy
23.43%
Upside
Reiterated
11/01/25
UBS Analyst forecast on HK:2607
Unknown Analyst
UBS
Not Ranked
UBS
HK$15
Buy
25.94%
Upside
Reiterated
10/31/25
Bank of America Securities Analyst forecast on HK:2607
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$14.3
Buy
20.07%
Upside
Reiterated
08/29/25
Morgan Stanley Analyst forecast on HK:2607
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$17
Buy
42.74%
Upside
Reiterated
07/10/25
Guotai Haitong Analyst forecast on HK:2607
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$13.73
Buy
15.28%
Upside
Reiterated
05/06/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on HK:2607
Unknown Analyst
Citi
Not Ranked
Citi
HK$13.5
Buy
13.35%
Upside
Reiterated
04/13/26
Shanghai Pharmaceuticals Holding Co (SHPMF) Receives a Buy from Citi
HSBC Analyst forecast on HK:2607
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$12.1→HK$11.8
Sell
-0.92%
Downside
Reiterated
11/10/25
HSBC Remains a Sell on Shanghai Pharmaceuticals Holding Co (SHPMF)
CICC Analyst forecast on HK:2607
Unknown Analyst
CICC
Not Ranked
CICC
HK$14.7
Buy
23.43%
Upside
Reiterated
11/01/25
UBS Analyst forecast on HK:2607
Unknown Analyst
UBS
Not Ranked
UBS
HK$15
Buy
25.94%
Upside
Reiterated
10/31/25
Bank of America Securities Analyst forecast on HK:2607
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$14.3
Buy
20.07%
Upside
Reiterated
08/29/25
Morgan Stanley Analyst forecast on HK:2607
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$17
Buy
42.74%
Upside
Reiterated
07/10/25
Guotai Haitong Analyst forecast on HK:2607
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$13.73
Buy
15.28%
Upside
Reiterated
05/06/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shanghai Pharmaceuticals Holding Co

3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+5.00%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.00% per trade.
1 Year
Henry Liu, CFAUBS
Success Rate
2/2 ratings generated profit
100%
Average Return
+5.40%
Copying Henry Liu, CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.40% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+5.90%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +5.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2607 Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
3
2
0
0
1
Hold
0
0
0
0
0
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
0
0
1
In the current month, 2607 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2607 average Analyst price target in the past 3 months is 13.50.
Each month's total comprises the sum of three months' worth of ratings.

2607 Financial Forecast

2607 Earnings Forecast

The previous quarter’s earnings for 2607 were HK$0.18.
The previous quarter’s earnings for 2607 were HK$0.18.

2607 Sales Forecast

The previous quarter’s earnings for 2607 were HK$75.15B.
The previous quarter’s earnings for 2607 were HK$75.15B.

2607 Stock Forecast FAQ

What is HK:2607’s average 12-month price target, according to analysts?
Based on analyst ratings, Shanghai Pharmaceuticals Holding Co Ltd Class H’s 12-month average price target is 13.50.
    What is HK:2607’s upside potential, based on the analysts’ average price target?
    Shanghai Pharmaceuticals Holding Co Ltd Class H has 13.35% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Shanghai Pharmaceuticals Holding Co Ltd Class H a Buy, Sell or Hold?
          Shanghai Pharmaceuticals Holding Co Ltd Class H has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s share price target?
            The average share price target for Shanghai Pharmaceuticals Holding Co Ltd Class H is 13.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$13.50 ,and the lowest forecast is HK$13.50. The average share price target represents 13.35% Increase from the current price of HK$11.91.
              What do analysts say about Shanghai Pharmaceuticals Holding Co Ltd Class H?
              Shanghai Pharmaceuticals Holding Co Ltd Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Shanghai Pharmaceuticals Holding Co Ltd Class H?
                To buy shares of HK:2607, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.